Skip to main content
NCBI home page
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 2000 Apr;9(4):704–712. doi: 10.1110/ps.9.4.704

Crystal structure of adenosine kinase from Toxoplasma gondii at 1.8 A resolution.

W J Cook 1, L J DeLucas 1, D Chattopadhyay 1
PMCID: PMC2144604  PMID: 10794412

Abstract

Human infection with Toxoplasma gondii is an important cause of morbidity and mortality. Protozoan parasites such as T. gondii are incapable of de novo purine biosynthesis and must acquire purines from their host, so the purine salvage pathway offers a number of potential targets for antiparasitic chemotherapy. In T. gondii tachyzoites, adenosine is the predominantly salvaged purine nucleoside, and thus adenosine kinase is a key enzyme in the purine salvage pathway of this parasite. The structure of T. gondii adenosine kinase was solved using molecular replacement and refined by simulated annealing at 1.8 A resolution to an R-factor of 0.214. The overall structure and the active site geometry are similar to human adenosine kinase, although there are significant differences. The T. gondii adenosine kinase has several unique features compared to the human sequence, including a five-residue deletion in one of the four linking segments between the two domains, which is probably responsible for a major change in the orientation of the two domains with respect to each other. These structural differences suggest the possibility of developing specific inhibitors of the parasitic enzyme.

Full Text

The Full Text of this article is available as a PDF (4.9 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrahams J. P., Leslie A. G. Methods used in the structure determination of bovine mitochondrial F1 ATPase. Acta Crystallogr D Biol Crystallogr. 1996 Jan 1;52(Pt 1):30–42. doi: 10.1107/S0907444995008754. [DOI] [PubMed] [Google Scholar]
  2. Barton G. J. ALSCRIPT: a tool to format multiple sequence alignments. Protein Eng. 1993 Jan;6(1):37–40. doi: 10.1093/protein/6.1.37. [DOI] [PubMed] [Google Scholar]
  3. Bhaumik D., Datta A. K. Reaction kinetics and inhibition of adenosine kinase from Leishmania donovani. Mol Biochem Parasitol. 1988 Apr;28(3):181–187. doi: 10.1016/0166-6851(88)90002-3. [DOI] [PubMed] [Google Scholar]
  4. Britt R. H., Enzmann D. R., Remington J. S. Intracranial infection in cardiac transplant recipients. Ann Neurol. 1981 Feb;9(2):107–119. doi: 10.1002/ana.410090203. [DOI] [PubMed] [Google Scholar]
  5. Brünger A. T., Adams P. D., Clore G. M., DeLano W. L., Gros P., Grosse-Kunstleve R. W., Jiang J. S., Kuszewski J., Nilges M., Pannu N. S. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905–921. doi: 10.1107/s0907444998003254. [DOI] [PubMed] [Google Scholar]
  6. Chang C. H., Cha S., Brockman R. W., Bennett L. L., Jr Kinetic studies of adenosine kinase from L1210 cells: a model enzyme with a two-site ping-pong mechanism. Biochemistry. 1983 Feb 1;22(3):600–611. doi: 10.1021/bi00272a012. [DOI] [PubMed] [Google Scholar]
  7. DONOHUE J., TRUEBLOOD K. N. Base pairing in DNA. J Mol Biol. 1960 Dec;2:363–371. doi: 10.1016/s0022-2836(60)80047-2. [DOI] [PubMed] [Google Scholar]
  8. Dannemann B., McCutchan J. A., Israelski D., Antoniskis D., Leport C., Luft B., Nussbaum J., Clumeck N., Morlat P., Chiu J. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. Ann Intern Med. 1992 Jan 1;116(1):33–43. doi: 10.7326/0003-4819-116-1-33. [DOI] [PubMed] [Google Scholar]
  9. Datta A. K., Bhaumik D., Chatterjee R. Isolation and characterization of adenosine kinase from Leishmania donovani. J Biol Chem. 1987 Apr 25;262(12):5515–5521. [PubMed] [Google Scholar]
  10. Fisher M. N., Newsholme E. A. Properties of rat heart adenosine kinase. Biochem J. 1984 Jul 15;221(2):521–528. doi: 10.1042/bj2210521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Grant I. H., Gold J. W., Rosenblum M., Niedzwiecki D., Armstrong D. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS. 1990 Jun;4(6):519–521. [PubMed] [Google Scholar]
  12. Hawkins C. F., Bagnara A. S. Adenosine kinase from human erythrocytes: kinetic studies and characterization of adenosine binding sites. Biochemistry. 1987 Apr 7;26(7):1982–1987. doi: 10.1021/bi00381a030. [DOI] [PubMed] [Google Scholar]
  13. Iltzsch M. H., Uber S. S., Tankersley K. O., el Kouni M. H. Structure-activity relationship for the binding of nucleoside ligands to adenosine kinase from Toxoplasma gondii. Biochem Pharmacol. 1995 May 17;49(10):1501–1512. doi: 10.1016/0006-2952(95)00029-y. [DOI] [PubMed] [Google Scholar]
  14. Krug E. C., Marr J. J., Berens R. L. Purine metabolism in Toxoplasma gondii. J Biol Chem. 1989 Jun 25;264(18):10601–10607. [PubMed] [Google Scholar]
  15. Luft B. J. Potent in vivo activity of arprinocid, a purine analogue, against murine toxoplasmosis. J Infect Dis. 1986 Oct;154(4):692–694. doi: 10.1093/infdis/154.4.692. [DOI] [PubMed] [Google Scholar]
  16. Luft B. J., Remington J. S. AIDS commentary. Toxoplasmic encephalitis. J Infect Dis. 1988 Jan;157(1):1–6. doi: 10.1093/infdis/157.1.1. [DOI] [PubMed] [Google Scholar]
  17. Mathews I. I., Erion M. D., Ealick S. E. Structure of human adenosine kinase at 1.5 A resolution. Biochemistry. 1998 Nov 10;37(45):15607–15620. doi: 10.1021/bi9815445. [DOI] [PubMed] [Google Scholar]
  18. McCabe R., Remington J. S. Toxoplasmosis: the time has come. N Engl J Med. 1988 Feb 4;318(5):313–315. doi: 10.1056/NEJM198802043180509. [DOI] [PubMed] [Google Scholar]
  19. McNally T., Helfrich R. J., Cowart M., Dorwin S. A., Meuth J. L., Idler K. B., Klute K. A., Simmer R. L., Kowaluk E. A., Halbert D. N. Cloning and expression of the adenosine kinase gene from rat and human tissues. Biochem Biophys Res Commun. 1997 Feb 24;231(3):645–650. doi: 10.1006/bbrc.1997.6157. [DOI] [PubMed] [Google Scholar]
  20. Miller R. L., Adamczyk D. L., Miller W. H. Adenosine kinase from rabbit liver. I. Purification by affinity chromatography and properties. J Biol Chem. 1979 Apr 10;254(7):2339–2345. [PubMed] [Google Scholar]
  21. Miller R. L., Adamczyk D. L., Miller W. H., Koszalka G. W., Rideout J. L., Beacham L. M., 3rd, Chao E. Y., Haggerty J. J., Krenitsky T. A., Elion G. B. Adenosine kinase from rabbit liver. II. Substrate and inhibitor specificity. J Biol Chem. 1979 Apr 10;254(7):2346–2352. [PubMed] [Google Scholar]
  22. Mimouni M., Bontemps F., Van den Berghe G. Kinetic studies of rat liver adenosine kinase. Explanation of exchange reaction between adenosine and AMP. J Biol Chem. 1994 Jul 8;269(27):17820–17825. [PubMed] [Google Scholar]
  23. Nash P. B., Purner M. B., Leon R. P., Clarke P., Duke R. C., Curiel T. J. Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. J Immunol. 1998 Feb 15;160(4):1824–1830. [PubMed] [Google Scholar]
  24. Palella T. D., Andres C. M., Fox I. H. Human placental adenosine kinase. Kinetic mechanism and inhibition. J Biol Chem. 1980 Jun 10;255(11):5264–5269. [PubMed] [Google Scholar]
  25. Pfefferkorn E. R., Pfefferkorn L. C. Arabinosyl nucleosides inhibit Toxoplasma gondii and allow the selection of resistant mutants. J Parasitol. 1976 Dec;62(6):993–999. [PubMed] [Google Scholar]
  26. Recacha R., Talalaev A., DeLucas L. J., Chattopadhyay D. Toxoplasma gondii adenosine kinase: expression, purification, characterization, crystallization and preliminary crystallographic analysis. Acta Crystallogr D Biol Crystallogr. 2000 Jan;56(Pt 1):76–78. doi: 10.1107/s0907444999013840. [DOI] [PubMed] [Google Scholar]
  27. Rotllan P., Miras Portugal M. T. Adenosine kinase from bovine adrenal medulla. Eur J Biochem. 1985 Sep 2;151(2):365–371. doi: 10.1111/j.1432-1033.1985.tb09110.x. [DOI] [PubMed] [Google Scholar]
  28. Schwartzman J. D., Pfefferkorn E. R. Toxoplasma gondii: purine synthesis and salvage in mutant host cells and parasites. Exp Parasitol. 1982 Feb;53(1):77–86. doi: 10.1016/0014-4894(82)90094-7. [DOI] [PubMed] [Google Scholar]
  29. Siegel S. E., Lunde M. N., Gelderman A. H., Halterman R. H., Brown J. A., Levine A. S., Graw R. G., Jr Transmission of toxoplasmosis by leukocyte transfusion. Blood. 1971 Apr;37(4):388–394. [PubMed] [Google Scholar]
  30. Sigrell J. A., Cameron A. D., Jones T. A., Mowbray S. L. Structure of Escherichia coli ribokinase in complex with ribose and dinucleotide determined to 1.8 A resolution: insights into a new family of kinase structures. Structure. 1998 Feb 15;6(2):183–193. doi: 10.1016/s0969-2126(98)00020-3. [DOI] [PubMed] [Google Scholar]
  31. Singh B., Hao W., Wu Z., Eigl B., Gupta R. S. Cloning and characterization of cDNA for adenosine kinase from mammalian (Chinese hamster, mouse, human and rat) species. High frequency mutants of Chinese hamster ovary cells involve structural alterations in the gene. Eur J Biochem. 1996 Oct 15;241(2):564–571. doi: 10.1111/j.1432-1033.1996.00564.x. [DOI] [PubMed] [Google Scholar]
  32. Spychala J., Datta N. S., Takabayashi K., Datta M., Fox I. H., Gribbin T., Mitchell B. S. Cloning of human adenosine kinase cDNA: sequence similarity to microbial ribokinases and fructokinases. Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1232–1237. doi: 10.1073/pnas.93.3.1232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Yamada Y., Goto H., Ogasawara N. Purification and properties of adenosine kinase from rat brain. Biochim Biophys Acta. 1980 Dec 4;616(2):199–207. doi: 10.1016/0005-2744(80)90138-2. [DOI] [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES